MedPath

Cervical Cancer Screening Among Hispanic Women

Not Applicable
Completed
Conditions
Cervical Cancer
Interventions
Behavioral: DVD
Behavioral: Promotora
Registration Number
NCT01525433
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

In this study, 400 Hispanic women will be recruited and randomized to one of three interventions:

1. Control (no change);

2. A low-intensity information program, consisting of a video approach educating women on the importance of cervical cancer screening;

3. A higher intensity program consisting of the video plus a 'promotora' or lay-community health educator led intervention at the participant's home to encourage cervical cancer screening.

The investigators will compare which intervention is most effective in encouraging Hispanic women to undergo cervical cancer screening (Pap test)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
451
Inclusion Criteria
  • Female
  • 21 - 64 years of age
  • Hispanic or Latina
  • Resident of the Yakima Valley, WA, USA
  • No hysterectomy
  • Last PAP test (cervical screening) more than 3 years ago
  • Last seen at the local clinic less than 5 years ago
Exclusion Criteria
  • Less than 21 or greater than 64 years of age
  • PAP test less 3 years ago
  • Prior hysterectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low Intensity Information (DVD)DVDA low-intensity information program, consisting of a video approach educating women on the importance of cervical cancer screening;
High Intensity Information (Promotora)PromotoraA higher intensity information program consisting of the video plus a 'promotora' or lay-community health educator led-intervention at the participant's home to encourage cervical cancer screening.
Primary Outcome Measures
NameTimeMethod
Participant attends cervical cancer screeningWithin 7 months of the intervention
Secondary Outcome Measures
NameTimeMethod
Patient NavigatorElapsed time from diagnosis to clinic visit

Evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among study participants who receive an abnormal Pap test result. Time to follow-up will be compared to a similar population of patients who were not part of the study who also receive a diagnosis of an abnormal Pap test.

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath